<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD) and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VD) are two major dementing disorders in Japan </plain></SENT>
<SENT sid="1" pm="."><plain>It has been well established that <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> E4 (ApoE4) increases the incidence of AD and lower the <z:hpo ids='HP_0003674'>onset</z:hpo> of AD in a dose-dependent manner </plain></SENT>
<SENT sid="2" pm="."><plain>ApoE genotyping should not be used alone in the diagnosis of AD due to its limited sensitivity to detect AD </plain></SENT>
<SENT sid="3" pm="."><plain>In VD, at the present time, no genetic risk factors that are directly linked to VD have been established </plain></SENT>
<SENT sid="4" pm="."><plain>However, <z:chebi fb="0" ids="25297">methylenetetrahydrofolate</z:chebi> reductase gene polymorphism may be a candidate conferring a risk to develop <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular diseases</z:e> </plain></SENT>
</text></document>